Pål Aukrust
- Inflammatory markers and COPD phenotypes as predictors of COPD exacerbationsBy Solveig Tangedal, Marianne Aanerud, Pål Aukrust, Gunnar Husebø, Jon Hardie, Louise Persson, Per Bakke and Tomas EaganSolveig Tangedal1Dept. of Thoracic Medicine, Haukeland University Hospital, Bergen, NorwayMarianne Aanerud1Dept. of Thoracic Medicine, Haukeland University Hospital, Bergen, NorwayPål Aukrust2Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, NorwayGunnar Husebø1Dept. of Thoracic Medicine, Haukeland University Hospital, Bergen, NorwayJon Hardie1Dept. of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway3Dept. of Clinical Science, University of Bergen, Bergen, NorwayLouise Persson1Dept. of Thoracic Medicine, Haukeland University Hospital, Bergen, NorwayPer Bakke3Dept. of Clinical Science, University of Bergen, Bergen, NorwayTomas Eagan1Dept. of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway3Dept. of Clinical Science, University of Bergen, Bergen, Norway
- Inflammasome ASC-knock out attenuates the development of pulmonary hypertension caused by chronic alveolar hypoxiaBy Fadila Telarevic Cero, Karl Otto Larsen, Vigdis Hillestad, Ivar Sjaastad, Arne Yndestad, Pål Aukrust, Egil Lien, Else Marit Løberg, Geir Christensen and Ole Henning SkjønsbergFadila Telarevic Cero1Department of Pulmonary Medicine, Oslo University Hospital, Ullevål, Oslo, Norway2Institute for Experimental Medical Research, Oslo University Hospital, Ullevål, Oslo, Norway3Center for Heart Failure Research, Oslo University Hospital, Ullevål, Oslo, NorwayKarl Otto Larsen1Department of Pulmonary Medicine, Oslo University Hospital, Ullevål, Oslo, NorwayVigdis Hillestad2Institute for Experimental Medical Research, Oslo University Hospital, Ullevål, Oslo, Norway3Center for Heart Failure Research, Oslo University Hospital, Ullevål, Oslo, NorwayIvar Sjaastad2Institute for Experimental Medical Research, Oslo University Hospital, Ullevål, Oslo, Norway3Center for Heart Failure Research, Oslo University Hospital, Ullevål, Oslo, NorwayArne Yndestad3Center for Heart Failure Research, Oslo University Hospital, Ullevål, Oslo, Norway4Research Institute of Internal Medicine, Oslo University Hospital, RiksHospitalet, Oslo, Norway5K.G.Jebsen Inflammation Research Centre, Institute of Clinical Medicine, Oslo, NorwayPål Aukrust4Research Institute of Internal Medicine, Oslo University Hospital, RiksHospitalet, Oslo, Norway5K.G.Jebsen Inflammation Research Centre, Institute of Clinical Medicine, Oslo, NorwayEgil Lien6Medicine, University of Massachusetts Medical School, Worcester,Else Marit Løberg7Department of Pathology, Oslo University Hospital, Ullevål, Oslo, NorwayGeir Christensen2Institute for Experimental Medical Research, Oslo University Hospital, Ullevål, Oslo, Norway3Center for Heart Failure Research, Oslo University Hospital, Ullevål, Oslo, NorwayOle Henning Skjønsberg1Department of Pulmonary Medicine, Oslo University Hospital, Ullevål, Oslo, Norway
- Macrophage migration inhibitory factor (MIF), a biomarker in COPD?By Gunnar Husebø, Per Bakke, Jon Hardie, Thor Ueland, Rune Grønseth, Pål Aukrust and Tomas EaganGunnar Husebø1Dept. of Thoracic Medicine, Haukeland University Hospital, Bergen, NorwayPer Bakke1Dept. of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway2Dept. of Clinical Science, University of Bergen, Bergen, NorwayJon Hardie2Dept. of Clinical Science, University of Bergen, Bergen, NorwayThor Ueland3Research Institute of Internal Medicine, Oslo University Hospital RiksHospitalet, Oslo, NorwayRune Grønseth1Dept. of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway2Dept. of Clinical Science, University of Bergen, Bergen, NorwayPål Aukrust3Research Institute of Internal Medicine, Oslo University Hospital RiksHospitalet, Oslo, NorwayTomas Eagan1Dept. of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway2Dept. of Clinical Science, University of Bergen, Bergen, Norway
- The inflammasome adaptor ASC mediates pulmonary artery remodellingBy Fadila Telarevic Cero, Karl Otto Larsen, Vigdis Hillestad, Maria Belland Olsen, Camilla Udjus, Ivar Sjaastad, Arne Yndestad, Pål Aukrust, Else Marit Løberg, Geir Christensen and Ole Henning SkjønsbergFadila Telarevic Cero1Department of Pulmonary Medicine, Oslo University Hospital, Ullevål, Oslo, Norway2Institute for Experimental Medical Research, Oslo University Hospital, Ullevål, Oslo, Norge Norway3Center for Heart Failure Research, University of Oslo, Oslo, Norge NorwayKarl Otto Larsen1Department of Pulmonary Medicine, Oslo University Hospital, Ullevål, Oslo, NorwayVigdis Hillestad2Institute for Experimental Medical Research, Oslo University Hospital, Ullevål, Oslo, Norge Norway3Center for Heart Failure Research, University of Oslo, Oslo, Norge NorwayMaria Belland Olsen3Center for Heart Failure Research, University of Oslo, Oslo, Norge Norway4Research Institute of Internal Medicine, Oslo University Hospital, RiksHospitalet, Oslo, Norge NorwayCamilla Udjus1Department of Pulmonary Medicine, Oslo University Hospital, Ullevål, Oslo, Norway2Institute for Experimental Medical Research, Oslo University Hospital, Ullevål, Oslo, Norge Norway3Center for Heart Failure Research, University of Oslo, Oslo, Norge NorwayIvar Sjaastad2Institute for Experimental Medical Research, Oslo University Hospital, Ullevål, Oslo, Norge Norway3Center for Heart Failure Research, University of Oslo, Oslo, Norge NorwayArne Yndestad3Center for Heart Failure Research, University of Oslo, Oslo, Norge Norway4Research Institute of Internal Medicine, Oslo University Hospital, RiksHospitalet, Oslo, Norge NorwayPål Aukrust4Research Institute of Internal Medicine, Oslo University Hospital, RiksHospitalet, Oslo, Norge NorwayElse Marit Løberg5Department of Pathology, Oslo University Hospital, Ullevål, Oslo, Norge NorwayGeir Christensen2Institute for Experimental Medical Research, Oslo University Hospital, Ullevål, Oslo, Norge Norway3Center for Heart Failure Research, University of Oslo, Oslo, Norge NorwayOle Henning Skjønsberg1Department of Pulmonary Medicine, Oslo University Hospital, Ullevål, Oslo, Norway
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.